Cart Is Empty
770-729-2992
- View all product options
| CODE | Protein Size | Price | ||
|---|---|---|---|---|
|
230-01103-100
|
$249.00 | ||
|
230-01103-250
|
$421.00 |
Please login to download this attachment
Product Specifications
Size:
100 ug or 250 ug
Format:
Liquid
Formulation:
Filtered solution in 50 mM Tris-HCl, 500 mM NaCl, 600 mM arginine, 2 mM oxidized glutathione, 4 mM reduced glutathione, 0.2% PEG4000, 20% glycerol (pH 8.5).
Purification:
His-tag affinity purification by immobilized metal ion affinity chromatography (IMAC)
Concentration (lot specific):
Lot specific (see the label on the vial), determined by Bradford protein assay.
Purity:
>95 %
Purity determined by:
SDS-PAGE under reducing conditions and visualized by Coomassie blue staining
Source
Species:
SARS-CoV-2
Accession Number:
- QHD43416
Expressed Region:
Met697 - Pro1213
Protein Name & Synonyms:
SARS-CoV-2 Spike Protein, S2 Subunit, S protein, spike protein
Preparation
Expression System:
Escherichia coli (E.coli)
Tag:
His
Conjugation/Tag Notes:
N-terminal histidine tag
Molecular Weight (kDa):
∼58 kDa
SDS-PAGE Image
Stability & Storage
Shipping
Ice packs
Storage/Stability
Upon arrival, the protein may be stored for 2 weeks at 4 °C. For long term storage, it is recommended to store at -20 °C or -80 °C in appropriate aliquots. Avoid repeated freeze-thaw cycles.
Related Coronavirus Proteins
Spike Protein, S1 Subunit
Spike Protein, S1 Subunit, Host Cell RBD
Nucleocapsid Protein
S1 Subunit Protein (RBD) with C-terminal Fc tag
S1 Subunit Protein (RBD) with C-terminal His-tag
S1 Subunit Protein with C-terminal His-tag
S2 Subunit Protein with C-terminal His-tag
Nucleocapsid Protein with C-terminal His-tag
-
Prompetchara E, et al. DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice. PLOS ONE 16(3): e0248007 (2021).
Species:
Sample type: -
Bortolotti D, et al. SARS-CoV-2 spike 1 protein controls natural killer cell activation via the HLA-E/NKG2A pathway. Cells (2020).
Species:
Sample type: -
Bray RA, et al. Development and validation of a multiplex, bead-based assay to detect antibodies directed against SARS-CoV-2 proteins. Buzhdygan TP, et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis. 146: 105131 (2020).
Species:
Sample type: -
Yu J, et al. Direct activation of the alternative complement pathway by SARS-CoV-2 spike protein is blocked by factor D inhibition. Blood. 2020 Sep 2;blood.2020008248 (2020).
Species:
Sample type:
No posts found
Usage
This product is furnished for LABORATORY RESEARCH USE ONLY.
Not for diagnostic or therapeutic use.
Related Products
Customers Also Bought
